{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["95(5)"],"submitter":["Dorward J"],"funding":["Africa Oxford Initiative","Global Challenges Research Fund","National Institute for Health and Care Research","Wellcome Trust"],"journal":["Journal of acquired immune deficiency syndromes (1999)"],"pagination":["e8-e11"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10927299"],"repository":["biostudies-literature"],"pubmed_title":["Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy."],"pmcid":["PMC10927299"],"funding_grant_id":["216421","MIC-2016-018","216421/Z/19/Z","0007365","AfiOx-119"],"pubmed_authors":["Bodley N","Samsunder N","Hayward G","Sookrajh Y","Singh L","Drain PK","Lessells R","Butler CC","Bulo E","Moodley P","Garrett N","Dorward J"],"additional_accession":[]},"is_claimable":false,"name":"Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy.","description":null,"dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Apr","modification":"2026-06-27T03:16:29.131Z","creation":"2026-06-27T03:06:07.759Z"},"accession":"S-EPMC10927299","cross_references":{"pubmed":["38489494"],"doi":["10.1097/QAI.0000000000003385"]}}